Norton Implants Limited - Accounts to registrar (filleted) - small 22.3

Norton Implants Limited - Accounts to registrar (filleted) - small 22.3


IRIS Accounts Production v22.3.0.621 07193336 director 1.4.21 31.3.22 31.3.22 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure071933362021-03-31071933362022-03-31071933362021-04-012022-03-31071933362020-03-31071933362020-04-012021-03-31071933362021-03-3107193336ns16:EnglandWales2021-04-012022-03-3107193336ns15:PoundSterling2021-04-012022-03-3107193336ns11:Director12021-04-012022-03-3107193336ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3107193336ns11:SmallEntities2021-04-012022-03-3107193336ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-3107193336ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3107193336ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3107193336ns11:FullAccounts2021-04-012022-03-310719333612021-04-012022-03-3107193336ns11:CompanySecretary12021-04-012022-03-3107193336ns11:RegisteredOffice2021-04-012022-03-3107193336ns6:CurrentFinancialInstruments2022-03-3107193336ns6:CurrentFinancialInstruments2021-03-3107193336ns6:ShareCapital2022-03-3107193336ns6:ShareCapital2021-03-3107193336ns6:SharePremium2022-03-3107193336ns6:SharePremium2021-03-3107193336ns6:RetainedEarningsAccumulatedLosses2022-03-3107193336ns6:RetainedEarningsAccumulatedLosses2021-03-3107193336ns6:NetGoodwill2021-04-012022-03-3107193336ns6:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3107193336ns6:PlantMachinery2021-04-012022-03-3107193336ns6:NetGoodwill2021-03-3107193336ns6:NetGoodwill2022-03-3107193336ns6:NetGoodwill2021-03-3107193336ns6:LeaseholdImprovements2021-03-3107193336ns6:PlantMachinery2021-03-3107193336ns6:FurnitureFittings2021-03-3107193336ns6:LeaseholdImprovements2021-04-012022-03-3107193336ns6:FurnitureFittings2021-04-012022-03-3107193336ns6:LeaseholdImprovements2022-03-3107193336ns6:PlantMachinery2022-03-3107193336ns6:FurnitureFittings2022-03-3107193336ns6:LeaseholdImprovements2021-03-3107193336ns6:PlantMachinery2021-03-3107193336ns6:FurnitureFittings2021-03-3107193336ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3107193336ns6:WithinOneYearns6:CurrentFinancialInstruments2021-03-3107193336ns11:Director112021-03-3107193336ns11:Director112020-03-3107193336ns11:Director112021-04-012022-03-3107193336ns11:Director112020-04-012021-03-3107193336ns11:Director112022-03-3107193336ns11:Director112021-03-31
REGISTERED NUMBER: 07193336 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2022

FOR

NORTON IMPLANTS LIMITED

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NORTON IMPLANTS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2022







DIRECTOR: Dr M R Norton





SECRETARY: Mrs L J Norton





REGISTERED OFFICE: 4th Floor
Charles House
108-110 Finchley Road
London
NW3 5JJ





REGISTERED NUMBER: 07193336 (England and Wales)





ACCOUNTANTS: Numera Partners LLP
4th Floor
Charles House
108-110 Finchley Road
London
NW3 5JJ

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

BALANCE SHEET
31 MARCH 2022

31.3.22 31.3.21
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 321,028 315,837
321,028 315,837

CURRENT ASSETS
Stocks 3,066 3,192
Debtors 6 235,143 389,922
Cash at bank 382,017 89,730
620,226 482,844
CREDITORS
Amounts falling due within one year 7 144,361 115,111
NET CURRENT ASSETS 475,865 367,733
TOTAL ASSETS LESS CURRENT
LIABILITIES

796,893

683,570

CAPITAL AND RESERVES
Called up share capital 100 100
Share premium 750,000 750,000
Retained earnings 46,793 (66,530 )
SHAREHOLDERS' FUNDS 796,893 683,570

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 November 2022 and were signed by:





Dr M R Norton - Director


NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022

1. STATUTORY INFORMATION

Norton Implants Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£) and rounded to the nearest £.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents invoiced sales of goods and services.

Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the identifiable assets and liabilities. It is amortised to the profit and loss account over its estimated useful life.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of section 11 'basic financial instruments' and section 12 'other financial instruments issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to contractual provisions of the instruments.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial instruments, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2021 - 3 ) .

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2021
and 31 March 2022 750,000
AMORTISATION
At 1 April 2021
and 31 March 2022 750,000
NET BOOK VALUE
At 31 March 2022 -
At 31 March 2021 -

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 April 2021 191,058 159,093 98,243 448,394
Additions - 15,767 - 15,767
At 31 March 2022 191,058 174,860 98,243 464,161
DEPRECIATION
At 1 April 2021 - 132,557 - 132,557
Charge for year - 10,576 - 10,576
At 31 March 2022 - 143,133 - 143,133
NET BOOK VALUE
At 31 March 2022 191,058 31,727 98,243 321,028
At 31 March 2021 191,058 26,536 98,243 315,837

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.22 31.3.21
£    £   
Trade debtors 18,713 26,913
Other debtors 216,430 363,009
235,143 389,922

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.22 31.3.21
£    £   
Trade creditors 23,089 18,541
Taxation and social security 106,849 84,149
Other creditors 14,423 12,421
144,361 115,111

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2022 and 31 March 2021:

31.3.22 31.3.21
£    £   
Dr M R Norton
Balance outstanding at start of year 360,777 404,181
Amounts advanced 413,252 561,013
Amounts repaid (559,890 ) (604,417 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 214,139 360,777

This balance was repaid after the year end.